Home Categories Info Network

Flavonoid Found In Rare Jamaican Weed Strain Could Treat Pancreatic Cancer

Permalink Report to webmaster

news  |  Jan 14, 2020

Flavonoid Found in Rare Jamaican Weed Strain Could Treat Pancreatic Cancer

The FDA has granted Orphan Drug status to a synthetic cannabis flavonoid, derived from a rare strain of Jamaican ganja, that can help treat pancreatic cancer.

The FDA has granted Orphan Drug status to a synthetic cannabis flavonoid, derived from a rare strain of Jamaican ganja, that can help treat pancreatic cancer.

The federal government has granted approval to a new series of clinical trials that will evaluate whether a cannabis flavonoid derived from a rare Jamaican strain of weed can help fight pancreatic cancer.

Most research into the medical properties of cannabis have focused on individual, well-known cannabinoids like THC and CBD. But last summer, a study published in the Frontiers in Oncology journal reported that cannflavin B — a flavonoid, not a cannabinoid — can help kill pancreatic cancer cells. This is an especially exciting development, since pancreatic cancer is one of the deadliest forms of this disease, with a bleak 8 percent survival rate.

In this study, researchers found that cannflavin B can cause cancer cells to essentially commit suicide, while also enhancing the effectiveness of standard chemotherapy and radiation therapies. Flavocure Biotech Inc, the company that funded this research, is not interested in using natural cannabis to fight cancer, however. Instead, they have used cannflavin B to help develop an anti-cancer drug known as Caflanone, or FBL-03G.

Source: https://merryjane.com/news/flavonoid-found-in-rare-jamaican-weed-strain-could-treat-pancreatic-cancer

Continue reading

Nobody has rated this post!
Vote now!
Cumulative results: 0 points • Rating: 0.000

Send a comment 0 comments

Leave a comment

Your name (required)
Your email (required)
Your website URL (optional):
Save your details in cookies (only on this browser)